Nexalin Technology Inc (NXL)

Mar 14, 2025

Nexalin Technology, Inc. SEC 10-K Report - TradingView

Mar 14, 2025

Mar 14, 2025

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Corsicana Daily Sun

Mar 14, 2025

Mar 13, 2025

Nexalin Technology’s Senior VP Makes a Bold Stock Purchase - TipRanks

Mar 13, 2025

Mar 13, 2025

Nexalin technology’s Sr. VP Carolyn Shelton acquires $13,200 in stock - Investing.com India

Mar 13, 2025

Mar 07, 2025

Nexalin Technology Stock Price, Quotes and Forecasts | NASDAQ:NXL - Benzinga

Mar 07, 2025

Mar 03, 2025

Nexalin Technology, Inc. Receives USPTO Notice of Allowance for Patent on Innovative Treatment Method for Opioid and Substance Use Disorders - Nasdaq

Mar 03, 2025

Mar 03, 2025

Nexalin Technology Receives Notice of Allowance from the - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

Could This Newly Patented Technology Transform How We Treat Addiction? - StockTitan

Mar 03, 2025

Mar 03, 2025

UCSD begins trial with Nexalin’s Halo Clarity device for mTBI and PTSD - Yahoo Finance

Mar 03, 2025

Feb 28, 2025

Nexalin Technology Announces Initiation of Patient - GlobeNewswire

Feb 28, 2025

Feb 28, 2025

Nexalin Technology, Inc. Launches Clinical Trial for HALO™ Clarity Device to Treat Mild Traumatic Brain Injury and PTSD at UCSD - Nasdaq

Feb 28, 2025

Feb 28, 2025

Nexalin Technology announces initiation of patient recruitment in UCSD study - TipRanks

Feb 28, 2025

Feb 28, 2025

Can Nexalin's Brain Stimulation Technology Transform PTSD Treatment? UCSD Trial Now Recruiting Patients - StockTitan

Feb 28, 2025

Feb 26, 2025

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board - EIN News

Feb 26, 2025

Feb 26, 2025

Nexalin Technology Appoints General Wesley Clark to Military & Government Advisory Board - citybiz

Feb 26, 2025

Feb 26, 2025

Can NATO's Former Supreme Commander Help Nexalin Crack the Military Mental Health Market? - StockTitan

Feb 26, 2025

Feb 19, 2025

Nexalin Secures UCSD IRB Approval For Use Of HALO Clarity In PTSD And MTBI Clinical Studies - Nasdaq

Feb 19, 2025

Feb 18, 2025

Nexalin Technology Announces UCSD IRB Approval for use of - GlobeNewswire

Feb 18, 2025

Feb 18, 2025

Nexalin Technology Announces UCSD IRB Approval For Use Of HALO Clarity In Clinical Trials For mTBI And PTSD Treatment - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Nexalin Technology Says Halo Clarity Headset Clinical Testing Gets UCSD Institutional Review Board Approval - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

Nexalin Technology, Inc. Receives IRB Approval for UCSD Clinical Trials of HALO™ Clarity Headset in Treating mTBI and PTSD - Nasdaq

Feb 18, 2025

Feb 18, 2025

Revolutionary Brain Treatment Device Enters Military PTSD Trials at UCSDPotential Breakthrough for Veterans - StockTitan

Feb 18, 2025

Feb 16, 2025

10,000 Shares in Nexalin Technology, Inc. (NASDAQ:NXL) Bought by Kingsview Wealth Management LLC - Defense World

Feb 16, 2025

Feb 13, 2025

Nexalin Technology Inc [NASDAQ: NXL] Sees Decrease in Stock Value - Knox Daily

Feb 13, 2025

Feb 11, 2025

Nexalin technology's chief medical officer buys $3,100 in shares - MSN

Feb 11, 2025

Feb 10, 2025

Nexalin Technology Inc’s latest rating changes from various analysts - Knox Daily

Feb 10, 2025

Feb 10, 2025

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition - GlobeNewswire

Feb 10, 2025

Feb 10, 2025

Nexalin Technology, Inc. Appointed Industry Co-Chair of National Traumatic Brain Injury Registry Coalition - Nasdaq

Feb 10, 2025

Feb 10, 2025

Nexalin (NXL) Secures Leadership Role in $4.5B Brain Injury MarketKey Details Investors Should See - StockTitan

Feb 10, 2025

Feb 08, 2025

Nexalin Technology announces effective registration statement - MSN

Feb 08, 2025

Feb 06, 2025

Nexalin Technology announces effective registration statement By Investing.com - Investing.com UK

Feb 06, 2025

Feb 06, 2025

Nexalin Technology Inc (NXL) Stock: A Year of Highs and Lows - The InvestChronicle

Feb 06, 2025

Feb 05, 2025

Nexalin Technology Inc (NXL) Becoming More Attractive for Investors - Knox Daily

Feb 05, 2025

Feb 05, 2025

Nexalin Technology announces publication of study of DIFS technology - MSN

Feb 05, 2025

Feb 05, 2025

Can you still get a good price for Nexalin Technology Inc (NXL) Shares at this point? - US Post News

Feb 05, 2025

Feb 05, 2025

Nexalin technology's chief medical officer buys $2,980 in common stock - MSN

Feb 05, 2025

Feb 04, 2025

Nexalin technology's chief medical officer buys $2,980 in common stock By Investing.com - Investing.com South Africa

Feb 04, 2025

Feb 04, 2025

Quoin Pharmaceuticals launches Netherton awareness campaign - MSN

Feb 04, 2025

Feb 03, 2025

Nexalin’s Breakthrough DIFS™ Neurostimulation Device - GlobeNewswire

Feb 03, 2025

Feb 03, 2025

Nexalin Technology, Inc. Reports Landmark Study Highlights Efficacy of DIFS™ Technology in Reducing Blood Pressure in Patients with Major Depressive Disorder - Nasdaq

Feb 03, 2025

Feb 03, 2025

Clinical Trial: New Depression Therapy Achieves Dual Brain and Heart Benefits - StockTitan

Feb 03, 2025

Feb 02, 2025

Reviewing Nexeon Medsystems (OTCMKTS:NXNN) and Nexalin Technology (NASDAQ:NXL) - Defense World

Feb 02, 2025

Feb 01, 2025

NXLNexalin Technology, Inc. Latest Stock News & Market Updates - StockTitan

Feb 01, 2025

Jan 30, 2025

Nexalin technology's chief medical officer buys $4,050 in stock - MSN

Jan 30, 2025